Isolated cutaneous myeloid sarcoma preceding acute myeloid leukemia: a case report and literature review
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Isolated cutaneous myeloid sarcoma (icMS) and aleukemic leukemia cutis (ALC) are cutaneous extramedullary manifestations of leukemia in which leukemic cells infiltrate the skin before they can be identified either in the peripheral blood or in the bone marrow. We report the case of a 67-year-old patient who presented with a rapidly developing cutaneous tumor and scaly, erythematous- squamous plaques. Isolated cutaneous myeloid sarcoma was diagnosed, which rapidly progressed to terminal-stage acute myeloid leukemia (AML). To highlight the disease characteristics of the adult-onset icMS and ALC cases that preceded AML, we additionally compiled the pertinent literature of case reports of these rare conditions. We identified 15 previously published icMS/ALC cases with adequately detailed clinical data descriptions. We could confirm medical experience that icMS/ALC patients have a worse overall prognosis. Moreover, we could identify FAB-M5 AML subtype as a significant adverse prognosticator in these patients.
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.